Migdal Insurance & Financial Holdings’s Bio-Techne TECH Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-19,744	Closed	-$1.22M	–	728
2020 Q3	$1.22M	Sell	19,744 -17,108	-46%	-$1.11M	0.02%	260
2020 Q2	$2.43M	Buy	36,852 +12,020	+48%	+$720K	0.04%	165
2020 Q1	$1.18M	Buy	24,832 +1,944	+8%	+$97.2K	0.03%	153
2019 Q4	$1.26M	Buy	22,888 +3,176	+16%	+$167K	0.02%	187
2019 Q3	$964K	Buy	19,712 +5,896	+43%	+$296K	0.02%	253
2019 Q2	$720K	Buy	13,816 +4,008	+41%	+$202K	0.02%	281
2019 Q1	$487K	Buy	9,808 +4,468	+84%	+$201K	0.01%	309
2018 Q4	$193K	Buy	+5,340	New	+$223K	﹤0.01%	386

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Migdal Insurance & Financial Holdings's TECH Position: Q4 2020 in Review

Migdal Insurance & Financial Holdings sold out of Bio-Techne (TECH) in Q4 2020, closing a stake of 19,744 shares — an estimated $1.22M sold.

Migdal Insurance & Financial Holdings first reported a position in TECH in Q4 2018 and held it in 8 quarters. The position peaked at $2.43M in Q2 2020. 441 funds tracked by Wall St. Rank hold TECH as of Q4 2020.

Migdal Insurance & Financial Holdings reported no remaining Bio-Techne position as of Q4 2020 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 19,744 Bio-Techne shares in Q4 2020, an estimated $1.22M.
Migdal Insurance & Financial Holdings first reported a position in Bio-Techne in Q4 2018 and held it in 8 quarters.
Migdal Insurance & Financial Holdings's Bio-Techne position peaked at $2.43M in Q2 2020.
441 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2020, filed 8 Feb 2021.